P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay

por Peachman, K, Wieczorek, L, Polonis, VR, Alving, CR, Rao, M
Publicado 2009

P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC

por Chenine, A, Sanders-Buell, E, Wieczorek, L, Kim, J, Polonis, V, Tovanabutra, S
Publicado 2009

Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates

por Gao, G, Peachman, KK, Wieczorek, L, Polonis, V, Alving, CR, Rao, M, Rao, VB
Publicado 2012

Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design

por Wieczorek, L, Rao, M, Peachman, K, Steers, N, Marovich, M, Michael, N, Polonis, V, Rao, V
Publicado 2012

Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide

por Matyas, GR, Jobe, O, Wieczorek, L, Peachman, KK, Beck, Z, Polonis, VR, Rao, M, Alving, CR
Publicado 2012

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes

por Matyas, GR, Wieczorek, L, Beck, Z, Ochsenbauer-Jambor, C, Kappes, JC, Michael, NL, Polonis, VR, Alving, CR
Publicado 2009

Absence of Ca(2+)-stimulated adenylyl cyclases leads to reduced synaptic plasticity and impaired experience-dependent fear memory

por Wieczorek, L, Majumdar, D, Wills, T A, Hu, L, Winder, D G, Webb, D J, Muglia, L J
Publicado 2012

P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β

por Weaver, KL, Peachman, KK, Boonnak, K, Wieczorek, L, Matyas, GR, Asher, LM, Polonis, VR, Marovich, M, Alving, CR, Rao, M
Publicado 2009

P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific

por Wieczorek, L, Brown, BK, Wesberry, M, Ochsenbauer-Jambor, C, Kappes, JC, Lora, N, Gillis, A, Nzodom, C, Molnar, S, Michael, NL, Montefiori, D, Polonis, VR
Publicado 2009

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays

por Brown, BK, Lombardi, K, Bryson, M, Currier, J, Thelian, D, Wieczorek, L, Kijak, G, Kappes, JC, Ochsenbauer-Jambor, C, Michael, NL, Montefiori, D, Polonis, VR
Publicado 2009

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development

por Polonis, V, Wieczorek, L, Kalyanaraman, V, Matyas, G, Whitney, S, Williams, C, Tovanabutra, S, Sanders-Buell, E, Wesberry, M, Ochsenbauer, C, Chenine, A, Rao, M, Tong, T, Alving, C, Cheng, H, Zolla-Pazner, S, Michael, N, VanCott, T, Marovich, M
Publicado 2012